Jaime Rosa Duque | Immunology | Best Researcher Award

Published on 24/03/202524/03/2025 by Global Academic Awards

Dr. Jaime Rosa Duque | Immunology | Best Researcher Award

Dr. Jaime Rosa Duque, The University of Hong Kong, Hong Kong

Dr. Jaime Sou Da Rosa Duque, MD, PhD, is a Clinical Assistant Professor at the University of Hong Kong specializing in paediatric immunology, allergy, and infectious diseases. He holds multiple board certifications and has completed fellowships at Stanford University. With extensive experience in paediatrics, he has contributed significantly to allergy research and immunology. His dedication to advancing child health has earned him honorary appointments and numerous awards, making him a distinguished leader in his field. 🌍🏅

Publication Profile

Orcid

🎓 Education

Dr. Duque earned his MD with Distinction in Research from the University of California, Irvine, and a PhD in Pharmacology and Toxicology. He holds a BS in Biochemistry from UCLA with Latin honors. His postgraduate training includes paediatrics at Children’s Hospital Los Angeles, followed by a prestigious fellowship in Allergy and Immunology at Stanford University. Additionally, he obtained a Diploma of Child Health from the UK. 📘👨‍🎓

Experience

Dr. Duque is a Clinical Assistant Professor at the University of Hong Kong and an Honorary Distinguished Professor at Guangzhou Medical University. His experience includes leadership roles at Hong Kong Children’s Hospital and Queen Mary Hospital. Previously, he served as a fellow at Stanford University, contributing to groundbreaking research in allergy and immunology. He has extensive experience in paediatric clinical care, academic mentorship, and collaborative research. 🏥📚

🏆 Awards and Honors

Dr. Duque has received numerous accolades, including Fellowships from the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Hong Kong Academy of Medicine. His research excellence has been recognized with prestigious grants and scholarships. Additionally, he serves in honorary academic roles at leading medical institutions in China and Hong Kong. His contributions to paediatric immunology and allergy are widely acclaimed. 🥇🌟

🔎 Research Focus

Dr. Duque’s research focuses on paediatric allergy, immunology, and infectious diseases. He investigates food allergies, anaphylaxis, and immune responses in paediatric patients. His work includes studies on drug allergies in Chinese children, neuropsychiatric syndrome, and immune risk factors. Through multidisciplinary research, he aims to advance treatment strategies and improve paediatric healthcare outcomes. His collaborations with global medical centers further enhance his impactful research. 🧬🔬

Publication Top Notes

🧒 Outcomes of pediatric patients with suspected allergies to COVID-19 vaccines (2025)
🧒 Development and validation of the Post-COVID Symptom Scale for Children/Youth (PCSS-C/Y) (2024)
🧒 Seroepidemiology of Measles and Rubella Among Hong Kong Young Adults and the Humoral Responses of a Measles-Mumps-Rubella Booster (2024
🧬 Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients (2024)
🐟 Combined Integrative RNA-Seq and Serological sIgE Analysis Enhances Understanding of Fish Allergen Profiles (2024)
🐟 Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross-reactivity and Reintroduction (2024)
🦠 PD1+CD4+ T cells promote receptor editing and suppress autoreactivity of CD19+CD21low B cells (2024)
💉 Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong (2024)
🐟 Real-World Sensitization and Tolerance Pattern to Seafood in Fish-Allergic Individuals (2024)
🧬 Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond (2024)

Xiang Yu | Regional Immunity | Best Researcher Award

Published on 11/03/202511/03/2025 by Global Academic Awards

Prof. Xiang Yu | Regional Immunity | Best Researcher Award

Prof. Xiang Yu, Hainan University, China

Prof. Xiang Yu is a distinguished immunologist and professor at Hainan University’s School of Biomedical Engineering. He specializes in regional immunity, with a focus on liver immunity and immune visualization. Holding a PhD from Huazhong University of Science and Technology, he has significantly contributed to tumor immunology and nanomedicine. Prof. Yu has published over 59 SCI-indexed papers, including highly cited works in Nature Communications and ACS Nano. His research innovations, including nanovaccines and biomimetic probes, have garnered international recognition. He has supervised numerous doctoral students and received multiple awards, including the Young Scholar Award from the Chinese Society of Immunology.

Publication Profile

Scopus

Orcid

Education 🎓📖

Prof. Xiang Yu obtained a Bachelor’s degree in Clinical Medicine from Wuhan University of Science and Technology in 2013. He later pursued a PhD in Biomedical Engineering at Huazhong University of Science and Technology, graduating in 2019. His doctoral research focused on immune microenvironment regulation, leading to groundbreaking findings in immune visualization and nanomedicine. During his academic journey, he developed expertise in tumor immunology, bio-nanotechnology, and immunotherapeutics. His education laid the foundation for his pioneering work in targeted liver immunity and innovative vaccine designs.

Experience 🏫🔬

Since 2019, Prof. Xiang Yu has been a professor of immunology at Hainan University, mentoring graduate students and leading cutting-edge research projects. His expertise in immune-targeted therapies has driven advancements in biomedical imaging and tumor vaccines. Over the years, he has published over 59 high-impact journal articles, collaborated on international research projects, and contributed to multiple patents. He also holds editorial roles in prestigious journals, serves as a reviewer for SCI-indexed publications, and has been an invited speaker at global immunology conferences.

Awards and Honors 🏆🎖

Prof. Yu has received four major awards, including the Young Scholar Award from the Chinese Society of Immunology. His groundbreaking research has been recognized with the Annual Best Paper Award by Journal of Nanobiotechnology. He has also earned two ESI Highly Cited Paper awards, highlighting his significant impact in immunology and nanomedicine. His students have won national and municipal prizes in academic competitions under his mentorship.

Research Focus 🔬🧬

Prof. Xiang Yu’s research revolves around regional immunity, particularly liver immunity and immune visualization. His work includes bee venom-based liver endothelial targeting, whole-tumor-cell nanovaccines, and biomimetic probes for inflammatory diseases. His studies have led to novel immune regulation strategies for cancer metastasis and autoimmune disorders. His interdisciplinary approach combines bioengineering, nanotechnology, and immunology to develop innovative diagnostic and therapeutic solutions.

Publication Top Notes

Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis (Nature Communications, 2019)
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response (Nature Communications, 2020)
Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles (Light: Science & Applications, 2020)
Biomimetic nanoplatform with selectively positioned indocyanine green for accurate sentinel lymph node imaging (Nanoscale, 2023)
Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death (Colloids and Surfaces B: Biointerfaces, 2025)
Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection (International Immunopharmacology, 2024)
Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice (International Journal of Molecular Sciences, 2024)
Mitochondrial stress response in drug-induced liver injury (Molecular Biology Reports, 2021)
Hematoxylin and eosin staining of intact tissues via delipidation and ultrasound (Scientific Reports, 2018)

Hadi Hassannia | Immunology | Best Researcher Award

Published on 10/10/202410/10/2024 by Global Academic Awards

Dr. Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia, Mazandaran University of Medical Sciences, Iran

Dr. Hadi Hassannia is a prominent researcher at the Amol Faculty of Paramedical Sciences and the Immunogenetic Research Center of Mazandaran University of Medical Sciences in Sari, Iran. His research focuses on cancer immunotherapy and vaccine development, with significant publications on tumor inhibition and insulin-producing cells from stem cells. Dr. Hassannia possesses advanced technical skills in genetic engineering, antibody production, and molecular techniques. His experience as a lab technician in diagnostic laboratories has enriched his practical knowledge in various fields, including hematology and immunology. He is committed to advancing cancer research and therapeutic approaches. 🧬🔬💉

Publication Profile

Google Scholar

Work Experience

Dr. Hassannia has a robust work history, having served as a lab technician in various diagnostic laboratories in governmental hospitals from 2009 to 2017. His practical experience in clinical settings enriches his research with a real-world perspective, further bridging the gap between laboratory findings and clinical applications.

Technical Skills

Dr. Hassannia possesses a diverse skill set that enhances his research capabilities:

Genetic Engineering: He has significant experience in genetic engineering, including protein manipulation and monoclonal antibody production.

Immunological Techniques: Proficient in advanced immunological techniques such as flow cytometry, Western blotting, and ELISA, he is well-equipped to conduct comprehensive immunological research.

Molecular Techniques: His expertise extends to molecular biology techniques like PCR and gene transfection, which are essential for cancer research and therapeutic development.

Laboratory Animal Handling: His experience with laboratory animals allows him to perform complex experiments, including tumor induction, vital for his research in cancer models.

Research Interests

Cancer Vaccine Development: His work in developing cancer vaccines contributes to the growing field of immunotherapy, which seeks to harness the body’s immune system to combat cancer.

Immunotherapy: He is engaged in research focused on immunotherapy approaches for cancer treatment, highlighting his commitment to improving patient outcomes.

Cancer-Related Inflammation: Understanding the role of inflammation in cancer progression is a critical area of his research, as it can lead to new therapeutic targets.

Tumor Metastasis: His interest in tumor metastasis is vital for understanding how cancer spreads and devising strategies to prevent it.

Conclusion

Dr. Hadi Hassannia’s extensive research experience, impressive publication record, and technical skills make him an exceptional candidate for the Best Researcher Award. His contributions to cancer research, particularly in immunotherapy and vaccine development, demonstrate his potential to impact the field significantly and advance medical science.

Publication Top Notes

CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice – Cited by: 165, Year: 2017 🧬
Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles – Cited by: 85, Year: 2016 📉
Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine – Cited by: 76, Year: 2020 💉
Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway – Cited by: 72, Year: 2019 🚀
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine – Cited by: 67, Year: 2020 ⚔️
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice – Cited by: 67, Year: 2018 🌱
Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model – Cited by: 59, Year: 2018 🌼
Myeloid-derived suppressor cells in B cell malignancies – Cited by: 59, Year: 2015 🦠
FOXP3 and TGF-β gene polymorphisms in allergic rhinitis – Cited by: 54, Year: 2011 🌿
Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers – Cited by: 53, Year: 2020 🧪

Saade Jasim | Immunology Award | Best Researcher Award

Published on 24/06/202424/06/2024 by Global Academic Awards

Assist Prof Dr. Saade Jasim | Immunology Award | Best Researcher Award

Assist Prof Dr. Saade Jasim, Fallujah university, Iraq

Dr. Saade Jasim is an Iraqi educator and researcher specializing in microbiology. He earned his Ph.D. from Al-Azhar University, Egypt, with expertise in anticancer nanocarriers and therapeutic applications of stem cell-derived vesicles. Dr. Jasim holds a strong academic background from Anbar and Tikrit Universities, focusing on biological sciences. His research, published in reputable journals, highlights his contributions to cancer treatment and autoimmune diseases. Fluent in Arabic and proficient in English, he excels in teamwork, time management, and handling pressure. Dr. Jasim’s technical skills include Microsoft Office and social media management. He resides in Ramadi, Iraq, dedicated to advancing education and scientific innovation. 📚

Publication profile

Scopus

Orcid

Google Scholar

Education

Dr. Saade Jasim, an accomplished Iraqi educator and researcher, was born on February 3rd, 1989, in Ramadi, Al Anbar, Iraq. He pursued his academic journey with a strong foundation in biological sciences, earning his Ph.D. in Microbiology from Al-Azhar University, Egypt, in 2022. Prior to this, he completed a Bachelor’s degree in Microbiology from Tikrit University in 2016 and a degree in Biology from Anbar University in 2012.

Research Focus

Dr. Saade Jasim’s research primarily focuses on the synthesis and application of advanced nanomaterials in various biomedical and environmental contexts. 🧬 His notable contributions include the development of magnetic nanocarriers for drug delivery, nanocomposites for catalytic reactions, and novel nanosorbents for environmental remediation. He explores the intersection of nanotechnology with microbiology and biotechnology, aiming to enhance therapeutic strategies and environmental sustainability. Dr. Jasim’s work also encompasses the study of mesenchymal stem cell-derived therapies for autoimmune diseases, underscoring his commitment to advancing both clinical and fundamental aspects of biomedicine. 🌱

Publication Top Notes

Hugues Piloquet | Immunology Award | Excellence in Academia Award

Published on 27/03/202427/03/2024 by Global Academic Awards

Dr. Hugues Piloquet | Immunology Award | Excellence in Academia Award

Dr. Hugues Piloquet, CHU de Nantes, University of Nantes, France

Dr. Hugues Piloquet is a distinguished pediatric gastroenterologist 🩺 with a career spanning over two decades. Graduating from the University of Nantes in 1989, he pursued specialized training in pediatric gastroenterology, hepatology, and nutrition. Dr. Piloquet has served in various prestigious roles, including as an Assistant at Necker Enfants Malades and later as a Practitioner at CHU de Nantes. His research contributions extend to INRA-France, where he was affiliated with the Physiology of Nutritional Adaptations unit. With expertise in pediatric gastrointestinal health, Dr. Piloquet continues to impact both clinical practice and research in his field.

Publication profile

Scopus

Education

Dr. Hugues Piloquet, born on July 18, 1965, embarked on his medical career with a Doctorate in Medicine from the University of Nantes in 1989. Specializing further, he obtained his DES in Pediatrics from the same institution in 1995, followed by a Master’s in Human Biology in 1993. His passion for pediatric gastroenterology led him to pursue advanced studies, including a DEA in Physiology and Pathophysiology of Human Nutrition from Paris VII. With a commitment to excellence, Dr. Piloquet completed a DIU in Pediatric Gastroenterology, Hepatology, and Nutrition in 1998.

Professional Experience 👨‍⚕️

Dr. Piloquet’s professional journey includes pivotal roles at esteemed institutions. He served as an Assistant at the Pediatric Gastroenterology Department under Pr. Claude Ricour at Necker Enfants Malades from 1995 to 1996. Progressing in his career, he assumed the role of Assistant-Chef de Clinique at the General Pediatrics Department under Pr. Alain Mouzard at CHU de Nantes in 1998. His dedication led him to become a Practitioner at CHU de Nantes in 1999, where he served as a hospital physician.

Research Focus

Dr. Hélène Piloquet’s research primarily focuses on pediatric nutrition and gastrointestinal health 🍼. She has contributed significantly to understanding the impact of early life gut microbiota on infant health, as evidenced by her work on synbiotic formulas and partially hydrolyzed whey-based follow-on formulas. Additionally, her studies explore the association between food fussiness in young children and family environmental factors. Through her research, Dr. Piloquet aims to optimize nutritional interventions for infants and toddlers, promoting healthy growth and development. Her interdisciplinary approach underscores the importance of nutrition in pediatric healthcare, addressing both clinical and environmental influences on children’s well-being.